Literature DB >> 5937401

Subcellular distribution and release by sympathetic nerve stimulation of dopamine and alpha-methyl dopamine.

J M Musacchio, J E Fischer, I J Kopin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5937401

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  9 in total

1.  Recent concepts in the clinical pharmacology of anithypertensive drugs.

Authors:  A S Nies; K L Melmon
Journal:  Calif Med       Date:  1967-05

2.  Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.

Authors:  H Thoenen; W Haefely; K F Gey; A Hürlmann
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

3.  Release of dopamine from central noradrenaline and dopamine nerves induced by a dopamine-beta-hydroxylase inhibitor.

Authors:  N E Andén; C V Atack; T H Svensson
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

4.  [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and chorea following the administration of alpha-methyldopa].

Authors:  E Gründig; F Gerstenbrand; J Bruck; H Gnad; P Prosenz; M Simanyi
Journal:  Dtsch Z Nervenheilkd       Date:  1969

5.  The release of 3H-dopamine from the isolated rabbit ileum.

Authors:  G G Collins; G B West
Journal:  Br J Pharmacol       Date:  1968-11       Impact factor: 8.739

6.  Release of noradrenaline and dopamine by nerve stimulation in the guinea-pig and rat vas deferens.

Authors:  C Bell; J S Gillespie; I M Macrae
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

7.  Fast axoplasmic transport of noradrenaline and dopamine in mammalian peripheral nerve.

Authors:  N Ben-Jonathan; R E Maxson; S Ochs
Journal:  J Physiol       Date:  1978-08       Impact factor: 5.182

8.  Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.

Authors:  A M Watanabe; L C Parks; I J Kopin
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

9.  A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.

Authors:  N E Andén; K Fuxe
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.